Stay up to date with the latest clinical business news in the industry!
- Senhwa Biosciences starts trial of silmitasertib in children with difficult to treat cancers
- Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist
- Streamlining eCOA: From complex setup to simplified solutions
- Starget Pharma’s AI-Driven Cancer Therapy Gains $5.1 Million Backing
- Palomar Health inspires youth with hands-on medical program
- FDA grants accelerated approval to Novartis’ Scemblix as a first-line leukemia therapy
- Novo Nordisk’s semaglutide shows additional cardiovascular benefits in overweight patients
- Thermo Fisher integrates Labguru ELN for streamlined lab management
- Top 10 rare disease pharma sees 10.4% rise in therapy start
- Abzena’s advanced drug development showcased at CPHI Milan